2024-12-16 - Analysis Report
## Hershey Co (HSY) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Hershey Co (HSY) is a leading producer of chocolate and confectionery products.  As of the last data point, HSY's cumulative return is 57.77%, significantly lagging behind the S&P 500's (VOO) cumulative return of 120.91%. The difference is -63.1%, placing it at the 5.4th percentile of its historical performance relative to the S&P 500.  This indicates underperformance compared to the broader market.  The provided alpha consistently shows 0.0, indicating no outperformance relative to market benchmarks, and a beta that fluctuates, demonstrating varying sensitivity to market movements.

**2. Recent Price Movement:**

* **Closing Price:** $183.10
* **5-Day Moving Average:** $184.98
* **20-Day Moving Average:** $177.09
* **60-Day Moving Average:** $181.34

The price is slightly below the 5-day moving average, suggesting some recent downward pressure. However, it is above both the 20-day and 60-day moving averages, indicating a potentially bullish short-term trend.

**3. Technical Indicators and Expected Return:**

* **RSI:** 57.18 (Slightly above neutral, suggesting neither overbought nor oversold conditions)
* **PPO:** 0.61 (Positive, indicating bullish momentum)
* **20-Day Relative Divergence:** +5.4 (Short-term upward trend relative to the S&P 500)
* **Expected Return:** 0.0% (This suggests that, based on the provided data, long-term (2+ years) investment in HSY is not expected to outperform the S&P 500. This should be interpreted cautiously given the limitations of the provided data)


The current price of $183.10 does not indicate a significant recent sharp increase or decrease.  The relatively low expected return warrants further investigation into potential catalysts for future growth.

**4. Recent Earnings Analysis:**

The provided earnings data reveals inconsistency in EPS performance against expectations:

* **2024-11-07:** EPS of 2.34 missed the expected 2.56.
* **2024-08-01:** EPS of 1.27 missed the expected 1.44.
* **2024-05-03:** EPS of 3.07 beat the expected 2.76.
* **2024-02-08:** EPS of 2.02 beat the expected 1.95.
* **2023-10-26:** EPS of 2.6 missed the expected 2.45.

While there's variability in meeting or exceeding expectations, there's no clear trend of consistent revenue growth or EPS increases.  Further analysis, including revenue figures, would be beneficial in fully understanding the earnings performance.  There is no information about revenue trends provided.

**5. Financial Information Analysis:**

* **Revenue:** Revenue shows fluctuation, without a clear upward trend.
* **Profit Margin:** Profit margins are generally high but also volatile, ranging from 40.19% to 51.53%.
* **Equity:** Equity is relatively stable.
* **ROE:** Return on Equity fluctuates significantly, indicating variable profitability.


The financial data reflects inconsistent performance across quarters.  Further analysis, including a look at the drivers behind these fluctuations, is necessary for a comprehensive understanding.

**6. News and Recent Issues:**

No recent earnings news (within the last two days) or market outlook/analyst opinions are provided.  This section requires additional data.


**7. Overall Analysis:**

HSY's performance has lagged behind the S&P 500, showing inconsistent earnings and financial performance. While some technical indicators suggest potential short-term bullish momentum, the low expected return and lack of clear upward trends in revenue and EPS raise concerns about long-term growth prospects.  The missing news and analyst opinions further limit the scope of a complete analysis.  More data, particularly regarding revenue trends and future expectations, is crucial for a more informed investment decision.


**8. Disclaimer:** This report is based solely on the limited data provided.  It should not be considered financial advice.  Independent research and consultation with a financial advisor are recommended before making any investment decisions.
